This paper is only available as a PDF. To read, Please Download here.
Objectives
We aimed to measure barriers to accessing abortion care in Indiana, a state with hostile
abortion policies that is anticipated to become even more restrictive.
Methods
Between June 2021 and April 2022, we recruited pregnant Indiana residents seeking
abortion via Google advertisements and other online posts, as well as through abortion
clinic waiting rooms and callers to local abortion funds. Participants completed a
self-administered, online survey at baseline, and a follow-up survey approximately
one month later to ascertain outcomes. We compared the proportion of people who reported
an abortion at endline by recruitment method and social and economic barriers experienced,
using chi-square tests of independence and multivariable logistic regression models.
Results
Overall, 351 participants completed the baseline survey and 205 (58%) participants
completed endline. Among those recruited from Google ads, 46% had an abortion compared
to 91% and 94% of participants recruited from an abortion fund or a clinic (p<0.01).
Participants who reported experiencing abortion stigma — specifically, their family
opposed abortion or they feared clinic protestors — (76% vs. 87%), who did not have
paid jobs (76% vs. 88%), and were uninsured (65% vs. 86%) were less likely to have
received an abortion than were those who did not report these experiences.
Conclusions
Anti-abortion sentiment and financial barriers prevented people from obtaining abortion
care in Indiana, while abortion funds facilitated access. As abortion becomes increasingly
restricted and likely clinically inaccessible in Indiana, facilitating connections
to abortion funds and combating abortion stigma are critical strategies to ensure
access to care.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to ContraceptionAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Article info
Identification
Copyright
© 2022 Published by Elsevier Inc.
